60 related articles for article (PubMed ID: 29863884)
1. Polymer Nanovesicle-Mediated Delivery of MLN8237 Preferentially Inhibits Aurora Kinase A To Target RalA and Anchorage-Independent Growth in Breast Cancer Cells.
Inchanalkar S; Deshpande NU; Kasherwal V; Jayakannan M; Balasubramanian N
Mol Pharm; 2018 Aug; 15(8):3046-3059. PubMed ID: 29863884
[TBL] [Abstract][Full Text] [Related]
2. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.
Do TV; Xiao F; Bickel LE; Klein-Szanto AJ; Pathak HB; Hua X; Howe C; O'Brien SW; Maglaty M; Ecsedy JA; Litwin S; Golemis EA; Schilder RJ; Godwin AK; Connolly DC
Oncogene; 2014 Jan; 33(5):539-49. PubMed ID: 23334327
[TBL] [Abstract][Full Text] [Related]
3. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
[TBL] [Abstract][Full Text] [Related]
4. Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.
Dos Santos EO; Carneiro-Lobo TC; Aoki MN; Levantini E; Bassères DS
Mol Cancer; 2016 Feb; 15():12. PubMed ID: 26842935
[TBL] [Abstract][Full Text] [Related]
5. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia.
Katsha A; Soutto M; Sehdev V; Peng D; Washington MK; Piazuelo MB; Tantawy MN; Manning HC; Lu P; Shyr Y; Ecsedy J; Belkhiri A; El-Rifai W
Gastroenterology; 2013 Dec; 145(6):1312-22.e1-8. PubMed ID: 23993973
[TBL] [Abstract][Full Text] [Related]
6. Modulation of oxidative phosphorylation augments antineoplastic activity of mitotic aurora kinase inhibition.
Zhang Z; Zeng D; Zhang W; Chen A; Lei J; Liu F; Deng B; Zhuo J; He B; Yan M; Lei X; Wang S; Lam EW; Liu Q; Wang Z
Cell Death Dis; 2021 Sep; 12(10):893. PubMed ID: 34593753
[TBL] [Abstract][Full Text] [Related]
7. AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses.
Meng B; Zhao X; Jiang S; Xu Z; Li S; Wang X; Ma W; Li L; Liu D; Zheng J; Peng H; Shi M
Front Immunol; 2023; 14():1182601. PubMed ID: 37781397
[TBL] [Abstract][Full Text] [Related]
8. CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2.
Li H; Wang Y; Lin K; Venkadakrishnan VB; Bakht M; Shi W; Meng C; Zhang J; Tremble K; Liang X; Song JH; Feng X; Van V; Deng P; Burks JK; Aparicio A; Keyomarsi K; Chen J; Lu Y; Beltran H; Zhao D
Cancer Res; 2022 Sep; 82(17):3088-3101. PubMed ID: 35771632
[TBL] [Abstract][Full Text] [Related]
9. A high-throughput small molecule screen identifies synergism between DNA methylation and Aurora kinase pathways for X reactivation.
Lessing D; Dial TO; Wei C; Payer B; Carrette LL; Kesner B; Szanto A; Jadhav A; Maloney DJ; Simeonov A; Theriault J; Hasaka T; Bedalov A; Bartolomei MS; Lee JT
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14366-14371. PubMed ID: 28182563
[TBL] [Abstract][Full Text] [Related]
10. A moving target: structure and disorder in pursuit of Myc inhibitors.
Bayliss R; Burgess SG; Leen E; Richards MW
Biochem Soc Trans; 2017 Jun; 45(3):709-717. PubMed ID: 28620032
[TBL] [Abstract][Full Text] [Related]
11. Discovery of N-benzylbenzamide-based allosteric inhibitors of Aurora kinase A.
Lee H; Kim E; Hwang N; Yoo J; Nam Y; Hwang I; Park JG; Park SE; Chung KS; Won Chung H; Song C; Ji MJ; Park HM; Lee IK; Lee KT; Joo Roh E; Hur W
Bioorg Med Chem; 2024 Mar; 102():117658. PubMed ID: 38460487
[TBL] [Abstract][Full Text] [Related]
12. Constitutive regulation of mitochondrial morphology by Aurora A kinase depends on a predicted cryptic targeting sequence at the N-terminus.
Grant R; Abdelbaki A; Bertoldi A; Gavilan MP; Mansfeld J; Glover DM; Lindon C
Open Biol; 2018 Jun; 8(6):. PubMed ID: 29899121
[TBL] [Abstract][Full Text] [Related]
13. Binding selectivity analysis of AURKs inhibitors through molecular dynamics simulation studies.
Alharthy RD; Fatima G; Yousaf N; Iqbal MS; Sattar S; Alanzi AR; Ali I; Muddassar M
PLoS One; 2023; 18(12):e0295741. PubMed ID: 38113210
[TBL] [Abstract][Full Text] [Related]
14. Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA.
Chen M; Zhu H; Li J; Luo D; Zhang J; Liu W; Wang J
Ann Med; 2024 Dec; 56(1):2282184. PubMed ID: 38738386
[TBL] [Abstract][Full Text] [Related]
15. Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner.
Tian J; Mallinger JC; Shi P; Ling D; Deleyrolle LP; Lin M; Khoshbouei H; Sarkisian MR
Transl Oncol; 2024 Jul; 45():101956. PubMed ID: 38640786
[TBL] [Abstract][Full Text] [Related]
16. Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile.
Mattei JC; Bouvier-Labit C; Barets D; Macagno N; Chocry M; Chibon F; Morando P; Rochwerger RA; Duffaud F; Olschwang S; Salas S; Jiguet-Jiglaire C
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32138169
[TBL] [Abstract][Full Text] [Related]
17. Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer.
Khan MS; Gowda BHJ; Nasir N; Wahab S; Pichika MR; Sahebkar A; Kesharwani P
Int J Pharm; 2023 Aug; 643():123276. PubMed ID: 37516217
[TBL] [Abstract][Full Text] [Related]
18. Scientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer.
Niu H; Manfredi M; Ecsedy JA
Front Oncol; 2015; 5():189. PubMed ID: 26380220
[TBL] [Abstract][Full Text] [Related]
19. Multitarget inhibitors/probes that target LRRK2 and AURORA A kinases noncovalently and covalently.
Wang W; Wang X; Tang G; Zhu C; Xiang M; Xiao Q; Zhang ZM; Gao L; Yao SQ
Chem Commun (Camb); 2023 Sep; 59(72):10789-10792. PubMed ID: 37594149
[TBL] [Abstract][Full Text] [Related]
20. Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes.
Banat R; Daoud S; Taha MO
Mol Divers; 2024 Mar; ():. PubMed ID: 38446372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
